Evidence map›Paper›PMID 35508994›Full record

ArticleBMC public health2022

Prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia, and associated risk factors in the Czech Republic, Russia, Poland and Lithuania: a cross-sectional study.

Wentian Lu, Hynek Pikhart, Abdonas Tamosiunas, Ruzena Kubinova, Nadezda Capkova, Sofia Malyutina, Andrzej Pająk, Martin Bobak

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Risk Effects of rs1799945 Polymorphism of theInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Wentian LuResearch Department of Epidemiology and Public Health, University College London, London, UK. wentian.lu.14@ucl.ac.uk.
Hynek PikhartResearch Department of Epidemiology and Public Health, University College London, London, UK.
Abdonas TamosiunasInstitute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Ruzena KubinovaNational Institute of Public Health, Prague, Czech Republic.
Nadezda CapkovaNational Institute of Public Health, Prague, Czech Republic.
Sofia MalyutinaResearch Institute of Internal and Preventive Medicine, Branch of "Federal Research Center Institute of Cytology and Genetics"(IC&G), Siberian Branch of RAS, Novosibirsk, Russia.
Andrzej PająkDepartment of Epidemiology and Population Studies, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
Martin BobakResearch Department of Epidemiology and Public Health, University College London, London, UK.
University College London · GBNational Institute of Public Health · CZInstitute of Cytology and Genetics · RUJagiellonian University · PLLithuanian University of Health Sciences · LT

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundEmpirical evidence on the epidemiology of hypertension, diabetes and hypercholesterolemia is limited in many countries in Central and Eastern Europe. We aimed to estimate the prevalence, awareness, treatment and control of hypertension, diabetes and hypercholesterolemia in the Czech Republic, Russia, Poland and Lithuania, and to identify the risk factors for the three chronic conditions.

methodsWe analysed cross-sectional data from the HAPIEE study, including adults aged 45-69 years in the Czech Republic, Russia, Poland and Lithuania, collected between 2002 and 2008 (total sample N = 30,882). Among prevalent cases, we estimated awareness, treatment, and control of hypertension, diabetes and hypercholesterolemia by gender and country. Multivariate logistic regression was applied to identify associated risk factors.

resultsIn each country among both men and women, we found high prevalence but low control of hypertension, diabetes, and hypercholesterolemia. Awareness rates of hypertension were the lowest in both men (61.40%) and women (69.21%) in the Czech Republic, while awareness rates of hypercholesterolemia were the highest in both men (46.51%) and women (51.20%) in Poland. Polish participants also had the highest rates of awareness (77.37% in men and 79.53% in women), treatment (71.99% in men and 74.87% in women) and control (30.98% in men and 38.08% in women) of diabetes. The common risk factors for the three chronic conditions were age, gender, education, obesity and alcohol consumption.

conclusionsPatterns of awareness, treatment and control rates of hypertension, diabetes and hypercholesterolemia differed by country. Efforts should be made in all four countries to control these conditions, including implementation of international guidelines in everyday practice to improve detection and effective management of these conditions.

Indexed as

Diabetes MellitusHypercholesterolemiaHypertensionAdultCross-Sectional StudiesCzech RepublicFemaleHumansLithuaniaMalePolandPrevalenceRisk FactorsRussiaBlood pressureCentral and Eastern EuropeDyslipidemiaFasting plasma glucoseTotal cholesterol

Identifiers

PMID35508994
PMCPMC9066905
OpenAlexW4225379396

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.